A Win For Impel NeuroPharma Inc.
Wed, Sep 13, 2023 at 07:21 PM
Impel NeuroPharma Inc. (IMPL:NASDAQ) soared at $0.8, representing a gain of 45%. On Wed, Sep 13, 2023, IMPL:NASDAQ touched a New 2-Week High of $0.8. From Wed, Aug 30, 2023, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Wed, Sep 13, 2023 at $1.12 with a volume of 36M+.
About Impel NeuroPharma Inc. (IMPL:NASDAQ)
Impel NeuroPharma Inc is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases...
Top 10 Gainers:
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 81.13%
- ZyVersa Therapeutics Inc Com Stk (ZVSA:NASDAQ), 47.86%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 44.98%
- BitNile Metaverse Inc Com (New) (BNMV:NASDAQ), 44.31%
- Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ), 38.85%
- SRAX, Inc. (SRAX:NASDAQ), 33.33%
- DASAN Zhone Solutions, Inc. (DZSI:NASDAQ), 32.24%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 31.96%
- SHF Holdings Inc Cl A (SHFS:NASDAQ), 25.68%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 25.13%